Returned Medical Devices: From Receipt to a Release Decision

Key point — A refund or replacement decision does not establish that a returned device can be released again. Use one return identifier to connect its condition, investigation and disposition.

Record the reason and the condition separately

Cancelled orders, excess stock, shipping damage and malfunctions can all generate returns. A cancelled order may still involve temperature excursions or damaged packaging. A malfunction may require technical investigation and safety assessment. The commercial return reason alone cannot establish product quality.

Record the product and model, lot or serial number, quantity, original shipment and recipient, reason, opening or use status, and circumstances. Mark unknown information explicitly. If the customer cannot name the failure, record observed symptoms and conditions rather than refusing the report.

Hold both the physical item and inventory status

A return recorded as ordinary incoming stock may be shipped before assessment. A practical approach uses a separate location or identification method and a system status outside saleable quantities. Link the return number, receipt date, owner and actual device identifiers.

KGMP Annex 2 section 8.3 requires controls for identifying, documenting, segregating, evaluating and disposing of nonconforming products. Not every return is automatically nonconforming, but an unevaluated device should not be treated as available stock. For used items with possible contamination, consider handler protection and manufacturer investigation conditions. Review the applicable scope with the KGMP overview.

Define product-specific release evidence

An unopened carton answers only part of this assessment. Appearance cannot fill a missing storage history. Define release criteria appropriate to the product's risks, including when missing evidence requires a hold or additional assessment. A brief manufacturer reassurance does not remove the need for a documented basis.

Separate investigation from disposition authorization

Possible outcomes include consideration for release, return to the manufacturer, legally permissible repair or rework, or disposal. Define the conditions and authorization for each path. Repair or rework is not permission to modify the device freely: the authorization, operator's lawful scope and applicable requirements still matter.

KGMP 8.3.4 calls for procedures that consider adverse effects of rework, review and approval, subsequent conformity verification and records. Cleaning or replacing packaging before resale should not be treated as a routine warehouse action. Release should cover identified units and quantities after the required evaluations have been completed.

Escalate safety signals found in returns

Repeated returns from one lot or reports of stopping during use, incorrect measurements or possible patient harm may extend beyond an individual transaction. Complaint handling under KGMP 8.2.2 includes investigation, assessment of regulatory reporting, disposition and corrective action. Do not defer the safety assessment until the manufacturer's final report merely because the cause remains uncertain.

Assess whether other supplied products are affected and whether adverse-event reporting or recall action is needed. Connect Article 31 with the current reporting guide. Track refund completion and safety-case closure separately. Not every return is reportable; document the basis when reporting is not indicated.

Close only when quantities and evidence reconcile

If 12 units comprise eight approved for release, three returned to the manufacturer and one still under investigation, the whole case is not complete. Reconcile disposition quantities, movement evidence, approvers and open actions. Link released devices to subsequent shipment records.

Reviewing return patterns by reason, lot and model can reveal recurring problems. Clare Partners can examine how your regulatory decisions connect with quality records through a free preliminary review.

Official sources checked on 2026-09-28: Medical Device Manufacturing and Quality Management Standards, Notice 2026-46, Annex 2 sections 7.5.11, 8.2.2, 8.2.6 and 8.3; Medical Devices Act, Article 31. Tables and inventory status examples are practical recommendations, not individual product release decisions.